Metagenomic Sequencing Market

Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024

Report Code: BT 7350 Sep, 2019, by marketsandmarkets.com

[149 Pages Report] The metagenomic sequencing market is estimated to grow at a CAGR of 17.0% to reach USD 2.3 billion by 2024 from USD 1.0 billion in 2019. Market growth is largely driven by factors such as the significant applications of metagenomics in various fields, the various initiatives and funding from government & private bodies for large-scale sequencing projects, and the declining cost of sequencing.

Metagenomic Sequencing Market

The reagents & consumables segment accounted for the largest share of the metagenomic sequencing market in 2018.

On the basis of products & services, the metagenomic sequencing market is segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. Of all these segments, reagents & consumables accounted for the largest share of the market in 2018. Factors such as the continuous requirement of sequencing reagents by end users and the development & commercialization of high-quality reagents & kits are expected to drive the growth of the reagents & consumables market in the coming years.

Sample processing & library preparation accounted for the largest share of the metagenomic sequencing market in 2018

The large share of this segment can be attributed to the growing number of metagenome sequencing research projects being conducted, the availability of technically advanced and robust sample processing Based on workflow, the market has been segmented into sample processing & library preparation, sequencing, and data processing & analysis. In 2018, sample processing & library preparation accounted for the largest share of the metagenomic sequencing market. The large share of this segment can be attributed to the growing number of metagenome sequencing research projects being conducted and the availability of technically advanced and robust sample processing and library preparation assay kits.

The shotgun metagenomic sequencing technology is expected to witness the highest growth rate in the market during the forecast period.

On the basis of technology, the metagenomic sequencing market is segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, metatranscriptomics, and whole-genome sequencing & de-novo assembly. The shotgun metagenomic sequencing technology is expected to witness the highest growth rate in the metagenomic sequencing market during the forecast period. This can be attributed to the advantages offered by shotgun sequencing over other techniques, growing adoption of shotgun metagenomic sequencing among researchers and healthcare professionals, and the increasing number of metagenomic sequencing-based research activities.

In 2018, the drug discovery segment accounted for the largest share of the metagenomic sequencing market

Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological and environmental applications, veterinary applications, and other applications. The drug discovery segment accounted for the largest share of the metagenomic sequencing market in 2018. Growth in this market segment is mainly due to the increasing research activities for novel drug discovery, growing collaborations between market players, academic institutions, and pharmaceutical companies for drug development, and growing use of metagenomic NGS in clinical trials.

North America accounted for the largest share of the metagenomic sequencing market in 2018

This report covers the metagenomic sequencing market across four major geographies-North America, Europe, the Asia Pacific, and the Rest of the World. North America commanded the largest share of the metagenomic sequencing market in 2018. This can primarily be attributed to favorable initiatives by government and private bodies for the development and adoption of NGS-based metagenomics technologies, the wide adoption of metagenomic diagnostics in the region, increasing number of NGS-based metagenomic research & clinical applications in the region, and rising awareness of metagenomics sequencing services.

Metagenomic Sequencing Market

Key Market Players

Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US), QIAGEN N.V. (Netherlands), PerkinElmer (US), Oxford Nanopore Technologies Ltd. (UK), BGI Group (China), Macrogen Inc. (South Korea), GENEWIZ (US), Eurofins Scientific (Luxembourg), Novogene Corporation (China), Zymo Research Corporation (US), NuGEN Technologies, Inc (US), IntegraGen SA (France), Microsynth AG (Switzerland), and DNAStar, Inc (US) are some of the leading players operating in the metagenomic sequencing market.

Illumina (US) dominates the next-generation sequencing market with its technologically advanced innovative platforms and associated sequencing products. The company’s product portfolio includes a wide range of highly interconnected products, including sequencing, genotyping, gene expression, and molecular diagnostic products. Illumina also offers metagenomic sequencing services, which further strengthens its market position. Over the past three years, Illumina has launched several products to maintain its leading position in the metagenomic sequencing market. It also invests a significant amount of its revenue on R&D expenditure in order to sustain continuous product development. In 2019, Illumina invested 18.7% of its revenue on R&D.

Thermo Fisher Scientific (US) offers an extensive range of products, including analytical instruments, equipment, reagents & consumables, software & services for research, analysis, discovery, and diagnostics. In addition to a robust portfolio of NGS products, (that include metagenomic sequencing products) the company also has a substantial geographic presence. Thermo Fisher Scientific launched a number of products in the past three years, including the Oncomine Childhood Cancer Research Assay and the Oncomine Immune Response Research Assay.

Scope of the report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019–2024

Currency Used

Value (USD Billion)

Segments Covered

Product & Service, Workflow, Technology, Application, and Region

Geographies Covered

North America, Europe, Asia Pacific, and RoW

Companies Covered

 

Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US), QIAGEN N.V. (Netherlands), PerkinElmer (US), Oxford Nanopore Technologies Ltd. (UK), BGI Group (China), Macrogen Inc. (South Korea), GENEWIZ (US), Eurofins Scientific (Luxembourg), Novogene Corporation (China), Zymo Research Corporation (US), NuGEN Technologies, Inc (US), IntegraGen SA (France), Microsynth AG (Switzerland), and DNAStar, Inc (US).

In this report, the metagenomic sequencing market has been segmented based on product & service, workflow, technology, application, and region.

Metagenomic Sequencing Market, by Product & Service

  • Reagents & Consumables
  • Instruments
  • Services
  • Analysis & Data Interpretation Solutions

Metagenomic Sequencing Market, by Workflow

  • Sample Processing & Library Preparation
  • Sequencing
  • Data Processing & Analysis

Metagenomic Sequencing Market, by Technology

  • Shotgun Metagenomic Sequencing
  • 16S rRNA Sequencing
  • Metatranscriptomics
  • Whole-genome Sequencing & De Novo Assembly

Metagenomic Sequencing Market, by Application

  • Drug Discovery
  • Clinical Diagnostics
  • Soil Microbiome Applications
  • Industrial applications
  • Ecological and Environmental Applications
  • Veterinary Applications
  • Other Applications

Metagenomic Sequencing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East
    • Africa

Recent Developments

Agreements, Partnerships, and Collaborations


Year

Nature of Agreement

Company 1

Company 2

DESCRIPTION

 

 

 

 

 

2019

Collaboration

Illumina

Lundbeck Foundation GeoGenetics Centre (Denmark)

The companies collaborated to generate one of the largest ancient genome datasets. This partnership will also help explore the relationship between the evolutionary history of select mental & neurological disorders and infectious pathogens.

2019

Collaboration

Illumina

KingMed Diagnostics (China)

The companies partnered to co-develop oncology & hereditary disease testing applications based on Illumina’s NGS technology.

2019

Agreement

Illumina

Thermo Fisher Scientific (US)

The companies entered into a commercial agreement for the sales of Thermo Fisher’s Ion AmpliSeq technology to researchers who use Illumina’s NGS platforms

2019

Partnership

QIAGEN N.V.

Multiple organizations in the UK

QIAGEN got into a partnership with multiple organizations in the UK to support and establish its global genomics campus in Manchester (UK). The new Genomic Health Innovation Campus will aim at innovation in life sciences, translational sciences, and the molecular diagnostics field.

Source: Press Releases

Acquisitions


Year

Company 1

Company 2

DESCRIPTION

2019

Illumina

Pacific Biosciences (US)

Illumina acquired Pacific Biosciences, one of the leading provider of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.

2019

Illumina

Edico Genome

Illumina acquired Edico Genome, a software provider for NGS.

2019

EUROFINS SCIENTIFIC

TestAmerica (US)

Eurofins Scientific acquired TestAmerica, a leading environmental testing laboratory group in the US. This helped Eurofins strengthen its presence in the US market.

2017

QIAGEN N.V.

OmicSoft Corporation (US)

QIAGEN acquired OmicSoft Corporation (US), a management, visualization, and analysis software provider for bioinformatics, NGS, and cancer genomics.

2016

QIAGEN N.V.

Exiqon A/S (Denmark)

This acquisition helped QIAGEN leverage Exiqon’s advanced Locked Nucleic Acid (LNA) technology to improve the sensitivity of PCR and NGS assays.

Source: Press Releases

Key Questions Addressed in This Reports

  • What are the strategies adopted by the top market players in the metagenomic sequencing market to penetrate emerging markets?
  • Who are the major players offering metagenome sequencing across major geographies?
  • Emerging countries offer opportunities for the adoption of metagenomic sequencing market. Will this scenario continue for the next five years?
  • What are the factors impacting the growth of metagenomic sequencing market globally?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency Used for the Study
    1.5 Market Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 Application-Based Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Metagenomic Sequencing: Market Overview
    4.2 Metagenomic Sequencing Market Share,  By Product & Service (2019 vs. 2024)
    4.3 Market Share, By Workflow (2019 vs. 2024)
    4.4 Market Share, By Technology (2019 vs. 2024)
    4.5 Market, By Application,  (2019 vs. 2024)
    4.6 Market, By Region (2019–2024)

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Significant Applications of Metagenomics in Various Fields
                    5.2.1.2 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
                    5.2.1.3 Declining Cost of Sequencing
           5.2.2 Restraints
                    5.2.2.1 End-User Budget Constraints in Developing Countries
           5.2.3 Opportunities
                    5.2.3.1 Availability of Cloud Computing for Data Management
           5.2.4 Challenges
                    5.2.4.1 Storage of Sequencing Data
                    5.2.4.2 Dearth of Skilled Professionals

6 Metagenomic Sequencing Market, By Product & Service (Page No. - 39)
    6.1 Introduction
    6.2 Reagents & Consumables
           6.2.1 Rising Adoption of Metagenomic Sequencing is Driving  the Use of Reagents and Consumables
    6.3 Instruments
           6.3.1 Launch of Advanced Ngs Platforms Will Support  the Growth of This Segment
    6.4 Services
           6.4.1 Time and Cost-Effectiveness of Outsourcing Ngs Projects has Driven Demand for Services
    6.5 Analysis and Data Interpretation Solutions
           6.5.1 Limited Technical Knowledge of Advanced Analysis Solutions Among End Users to Hamper Market Growth

7 Metagenomic Sequencing Market, By Workflow (Page No. - 45)
    7.1 Introduction
    7.2 Sample Processing & Library Preparation
           7.2.1 Sample Processing & Library Preparation Holds  the Largest Share of the Market, By Workflow
    7.3 Sequencing
           7.3.1 Sanger Sequencing has Been Supplanted By Ngs Due to Its Advantages and Rapidity
    7.4 Data Processing & Analysis
           7.4.1 Need for Skilled Personnel to Operate Data Processing and Analytics Tools has Slowed Market Growth

8 Metagenomic Sequencing Market, By Technology (Page No. - 49)
    8.1 Introduction
    8.2 16s Rrna Sequencing
           8.2.1 16s Rrna Sequencing is A Cost-Effective Technique for the Identification of Bacterial Strains
    8.3 Shotgun Metagenomic Sequencing
           8.3.1 Shotgun Metagenomic Sequencing Segment to Witness the Highest Growth Rate During the Forecast Period
    8.4 Whole-Genome Sequencing and De Novo Assembly
           8.4.1 Wgs Can Sequence the Complete Metagenome of Environmental Samples & Helps Generate Accurate Reference Genomes for Microbial Identification
    8.5 Metatranscriptomics
           8.5.1 Metatranscriptomics Helps in the Understanding of the Active Functional Profile of A Microbial Community

9 Metagenomic Sequencing Market, By Application (Page No. - 56)
    9.1 Introduction
    9.2 Drug Discovery
           9.2.1 Drug Discovery Accounts for the Largest Share of the Market
    9.3 Ecological & Environmental Applications
           9.3.1 Metagenomic Sequencing Can Help Identify Invasive and Endangered Species
    9.4 Clinical Diagnostics
           9.4.1 Advantages of Metagenomic Ngs Have Enabled Wide Applications in Diagnostics
    9.5 Soil Microbiome Applications
           9.5.1 North America Shows High Demand for Metagenomic Sequencing in Soil Microbiome Applications
    9.6 Industrial Applications
           9.6.1 Energy
                    9.6.1.1 Declining Fossil Fuel Reserves and Growing Energy Needs Will Drive Demand Growth in This Application Segment
           9.6.2 Bioremediation
                    9.6.2.1 Need to Monitor Pollutant Impact and Contamination Will Provide Opportunities for Metagenomic Sequencing in Bioremediation
           9.6.3 Other Industrial Applications
    9.7 Veterinary Applications
           9.7.1 Demand for Rapid and Accurate Pathogen Diagnosis is Supporting Demand for Sequencing
    9.8 Other Applications

10 Metagenomic Sequencing Market, By Region (Page No. - 67)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 Well-Established Infrastructure and Funding Sources Required for Overall Ngs Based Small- and Medium-Sized Research Studies and Projects Make the US the Largest Market in North America
             10.2.2 Canada
                        10.2.2.1 Growing Focus of Ngs Players on Expanding their Presence  in Canada and Increasing Government Initiatives to Support Genomics Research and Workshops to Support Growth in  This Market
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany has Witnessed A Significant Increase in Investments  in Next-Generation Technologies, Making It the Largest Market  in Europe
             10.3.2 UK
                        10.3.2.1 The UK is One of the Leaders in Biotechnology in the European Region Owing to the Presence of A Large Number of  Ngs Players in the Country
             10.3.3 France
                        10.3.3.1 Government Initiatives to Support Genomics Research are Primarily Driving the Growth of the Metagenomic  Sequencing Market in France
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 China
                        10.4.1.1 Several Ngs Players are Focusing on Strengthening their Presence and Offerings in China
             10.4.2 Japan
                        10.4.2.1 Rising Use of Metagenomic Sequencing for Various Application to Drive Market Growth in Japan
             10.4.3 India
                        10.4.3.1 Decreasing Cost of Sequencing to Drive Market Growth in India
             10.4.4 Rest of Asia Pacific
     10.5 Rest of the World
             10.5.1 Latin America
             10.5.2 Middle East
             10.5.3 Africa

11 Competitive Landscape (Page No. - 95)
     11.1 Introduction
     11.2 Market Ranking Analysis
     11.3 Competitive Scenario
             11.3.1 Acquisitions
             11.3.2 Agreements
     11.4 Competitive Leadership Mapping
             11.4.1 Competitive Leadership Mapping:  Major Market Players (2018)
             11.4.2 Visionary Leaders
             11.4.3 Innovators
             11.4.4 Dynamic Players
             11.4.5 Emerging Companies

12 Company Profiles (Page No. - 100)
     12.1 BGI Group
     12.2 DNAstar, Inc.
     12.3 Eurofins Scientific
     12.4 GENEWIZ
     12.5 Illumina, Inc.
     12.6 Integragen SA
     12.7 Macrogen, Inc.
     12.8 Microsynth AG
     12.9 Novogene Co., Ltd.
     12.10 NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
     12.11 Oxford Nanopore Technologies, Ltd.
     12.12 Perkinelmer, Inc.
     12.13 QIAGEN N.V.
     12.14 Thermo Fisher Scientific, Inc.
     12.15 Zymo Research Corporation

13 Appendix (Page No. - 142)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’  Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (60 Tables)

Table 1 Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 2 Metagenomic Sequencing Reagents and Consumables Market, By Region, 2017–2024 (USD Million)
Table 3 Metagenomic Sequencing Instruments Market, By Region, 2017–2024 (USD Million)
Table 4 Metagenomic Sequencing Services Market, By Region, 2017–2024 (USD Million)
Table 5 Metagenomic Sequencing Analysis and Data Interpretation Solutions Market, By Region, 2017–2024 (USD Million)
Table 6 Metagenomic Sequencing Market, By Workflow, 2017–2024 (USD Million)
Table 7 Sample Processing & Library Preparation Market, By Region, 2017–2024 (USD Million)
Table 8 Sequencing Market, By Region, 2017–2024 (USD Million)
Table 9 Data Processing & Analysis Market, By Region, 2017–2024 (USD Million)
Table 10 Market, By Technology, 2017–2024 (USD Million)
Table 11 16s Rrna Sequencing Market, By Region, 2017–2024 (USD Million)
Table 12 Shotgun Market, By Region, 2017–2024 (USD Million)
Table 13 Whole-Genome Sequencing and De Novo Assembly Market, By Region, 2017–2024 (USD Million)
Table 14 Metatranscriptomics Market, By Region, 2017–2024 (USD Million)
Table 15 Metagenomic Sequencing Market, By Application, 2017–2024 (USD Million)
Table 16 Market for Drug Discovery, By Region, 2017–2024 (USD Million)
Table 17 Market for Ecological & Environmental Applications, By Region, 2017–2024 (USD Million)
Table 18 Market for Clinic Diagnostics, By Region, 2017–2024 (USD Million)
Table 19 Metagenomic Sequencing Market for Soil Microbiome Applications, By Region, 2017–2024 (USD Million)
Table 20 Market for Industrial Applications, By Region, 2017–2024 (USD Million)
Table 21 Market for Industrial Applications, By Type, 2017–2024 (USD Million)
Table 22 Market for Energy, By Region, 2017–2024 (USD Million)
Table 23 Market for Bioremediation, By Region, 2017–2024 (USD Million)
Table 24 Metagenomic Sequencing Market for Other Industrial Applications, By Region, 2017–2024 (USD Million)
Table 25 Market for Veterinary Applications, By Region, 2017–2024 (USD Million)
Table 26 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 27 Metagenomic Sequencing Market, By Region, 2017–2024 (USD Million)
Table 28 North America: Market, By Country, 2017–2024 (USD Million)
Table 29 North America: Market, By Product & Service, 2017–2024 (USD Million)
Table 30 North America: Market, By Workflow, 2017–2024 (USD Million)
Table 31 North America: Market, By Technology, 2017–2024 (USD Million)
Table 32 North America: ncing Market, By Application, 2017–2024 (USD Million)
Table 33 US: Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 34 Canada: Market, By Product & Service, 2017–2024 (USD Million)
Table 35 Europe: Market, By Country, 2017–2024 (USD Million)
Table 36 Europe: Market, By Product & Service, 2017–2024 (USD Million)
Table 37 Europe: Market, By Workflow, 2017–2024 (USD Million)
Table 38 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 39 Europe: Market, By Application, 2017–2024 (USD Million)
Table 40 Germany: Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 41 UK: Market, By Product & Service, 2017–2024 (USD Million)
Table 42 France: Market, By Product & Service, 2017–2024 (USD Million)
Table 43 RoE: Market, By Product & Service, 2017–2024 (USD Million)
Table 44 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 45 Asia Pacific: Market, By Product & Service, 2017–2024 (USD Million)
Table 46 Asia Pacific: Market, By Workflow, 2017–2024 (USD Million)
Table 47 Asia Pacific: Metagenomic Sequencing Market, By Technology, 2017–2024 (USD Million)
Table 48 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 49 China: Market, By Product & Service, 2017–2024 (USD Million)
Table 50 Japan: Market, By Product & Service, 2017–2024 (USD Million)
Table 51 India: Market, By Product & Service, 2017–2024 (USD Million)
Table 52 RoAPAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 53 RoW: Market, By Region, 2017–2024 (USD Million)
Table 54 RoW: Market, By Product & Service, 2017–2024 (USD Million)
Table 55 RoW: Market, By Workflow, 2017–2024 (USD Million)
Table 56 RoW: Market, By Technology, 2017–2024 (USD Million)
Table 57 RoW: Market, By Application, 2017–2024 (USD Million)
Table 58 Latam: Market, By Product & Service, 2017–2024 (USD Million)
Table 59 Middle East: Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 60 Africa: Market, By Product & Service, 2017–2024 (USD Million)


List of Figures (30 Figures)

Figure 1 Metagenomic Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Product-Based Market Estimation: Market
Figure 5 Application-Based Market Size Estimation: Market
Figure 6 Metagenomic Sequencing Market: Data Triangulation
Figure 7 Market, By Product & Service, 2019 vs. 2024 (USD Million)
Figure 8 Market, By Workflow, 2019 vs. 2024 (USD Million)
Figure 9 Market, By Technology, 2019 vs. 2024 (USD Million)
Figure 10 Market, By Application, 2019 vs. 2024 (USD Million)
Figure 11 Market, By Region, 2019–2024
Figure 12 Significant Applications of Metagenomics in Various Fields to Drive Growth in the Market
Figure 13 Reagents & Consumables Held the Largest Share of the Market in 2018
Figure 14 Sample Processing & Library Preparation Accounted for the Largest Share of the Market in 2018
Figure 15 Shotgun Metagenomic Sequencing Technology is Expected to Witness the Highest Growth Rate During Forecast Period
Figure 16 Drug Discovery Segment Accounted for the Largest Share of the Metagenomic Sequencing Market During the Forecast Period
Figure 17 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 North America: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 Metagenomics Sequencing Market Ranking, By Key Player, 2018
Figure 22 Metagenomic Sequencing Market (Global) Competitive Leadership Mapping, 2018
Figure 23 Eurofins Scientific: Company Snapshot, 2018
Figure 24 Brooks Automation, Inc.: Company Snapshot, 2018
Figure 25 Illumina, Inc.: Company Snapshot, 2018
Figure 26 Integragen SA: Company Snapshot, 2018
Figure 27 Tecan Trading AG: Scientific: Company Snapshot, 2018
Figure 28 Perkinelmer, Inc.: Company Snapshot, 2018
Figure 29 QIAGEN N.V.: Company Snapshot, 2018
Figure 30 Thermo Fisher Scientific Inc.: Company Snapshot, 2018

This study involved four major activities in estimating the current size of the metagenomic sequencing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation processes were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was conducted to obtain key information about the market classification and segmentation, geographical scenario, key developments undertaken by major market players, and the identification of key industry trends. The secondary sources used for this study include annual reports, press releases, and investor presentations of companies; white papers; certified publications; and articles from recognized websites, databases, and directories.

Primary Research

Extensive primary research was conducted after acquiring a preliminary understanding of the metagenomic sequencing market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (include experts, such as perfusionists, surgeons, surgical technicians, and purchase managers of private & government hospitals) and supply-side respondents (such as C & D-level executives & product managers of key manufacturers, distributors, and channel partners) across North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 30% and 70% of primary interviews were conducted with both the demand- and supply-side respondents, respectively. Primary data was collected through questionnaires, e-mails, online surveys, and telephonic interviews. A breakdown of primary respondents is provided below:

Metagenomic Sequencing Market

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

  • A detailed market estimation approach was followed to estimate and validate the size of the market and other dependent submarkets.
  • The key players in the market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of top market players as well as interviews with industry experts to gather key insights on various market segments and subsegments.
  • All segmental shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • Major macroindicators in play have been accounted for, viewed in detail, verified through primary research, and analyzed to understand their impact on market growth and various segments and subsegments.
  • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation:

After deriving the overall metagenomic sequencing market value from the market size estimation process explained above, the total market value data was split into several segments and subsegments. Data triangulation and market breakdown procedures were undertaken to complete the overall market engineering process and arrive at the exact statistics for all segments, wherever applicable. The data was triangulated by studying various qualitative & quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Report Objectives:

  • To define, describe, and forecast the market on the basis of product & service, workflow, technology, application, and region
  • To provide detailed information regarding the major factors influencing the metagenomic sequencing market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the market
  • To analyze key growth opportunities in the market for key stakeholders and provide details of the competitive landscape for key market players
  • To forecast the market value of various segments and/or subsegments with respect to four major regional segments-North America, Europe, the Asia Pacific, and the Rest of the World
  • To profile the key players in the market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments undertaken by major players in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the metagenomic sequencing market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
BT 7350
Published ON
Sep, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Metagenomic Sequencing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home